Evidence map›Paper›PMID 23166285›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2013

The road to competitive generic drug prices in Canada.

Michael R Law, Jillian Kratzer

Abstract readHistorical Article
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. The Impact of Tiered-Pricing Framework on Generic Entry in Canada.International journal of health policy and management · 2022
    Article
  3. Ontario and New Zealand Pharmaceuticals: Cost and Coverage.Healthcare policy = Politiques de sante · 2018
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines.Open medicine : a peer-reviewed, independent, open-access journal · 2014
    Article
  10. Money left on the table: generic drug prices in Canada.Healthcare policy = Politiques de sante · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael R Law
Jillian Kratzer

Funding

Canadian Institutes of Health Research MOP-221233
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CanadaDrug CostsDrugs, GenericGroup PurchasingHistory, 20th CenturyHistory, 21st CenturyDrugs, Generic

Identifiers

PMID23166285
PMCPMC3778465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.